STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%
Wed, 31 Jul

STRIDES PHARMA SCIENCE has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m6,6358,3976,858-18.3%3.4%
Other incomeRs m106146103-29.7%-3.7%
TurnoverRs m6,7418,5436,961-18.5%3.3%
ExpensesRs m5,8276,8085,649-17.0%-3.1%
Gross profitRs m7581,6791,143-31.9%50.7%
DepreciationRs m429438429-2.1%0.0%
InterestRs m441627353-43.6%-19.9%
Profit before taxRs m-5760463-39.1%
TaxRs m-4311131-71.8%
Profit after taxRs m38650432-33.5%1048.1%
Gross profit margin%11.420.016.7
Effective tax rate%837.314.56.7
Net profit margin%0.67.66.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 3.4% on a year-on-year (YoY) basis. The expenses were down by 3.1% YoY during the same period.
  • The company's operating profit increased by 50.7% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 16.7% in 1QFY20 as against 11.4% in 1QFY19.
  • Depreciation charges increased by 0.0% and finance costs declined by 19.9% YoY, respectively.
  • Other income declined by 3.7% YoY during the quarter.
  • Net profit for the quarter increased by 1048.1% YoY. Net profit margins during the quarter increased from 0.6% in 1QFY19 to 6.2% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 18.3% on a quarter-on-quarter (QoQ) basis. The expenses were down by 17.0% QoQ during the same period.
  • The company's operating profit declined by 31.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 16.7% in 1QFY20 as against 20.0% in 4QFY19.
  • Net profit for the quarter declined by 33.5% QoQ, while net profit margins declined from 7.6% in 4QFY19 to 6.2% in 1QFY20.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters,please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year,STRIDES PHARMA SCIENCE share price has moved down from Rs 384.7 to Rs 374.7, registering a Loss of Rs 10.0 or around 2.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,557.7 (down 0.2%). Over the last one year it has moved down from 14,205.7 to 12,557.7, a gain of 1,648 points (down 11.6%).

Overall, the S&P BSE SENSEX is down 0.7% over the year.

Current Valuations

At the current price of Rs 374.7, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 15.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 0.9 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

I Made a Killing in the Markets this Week... Here's How(Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Jan 20, 2020 09:19 AM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS